The funding round was backed by investors including Greenwood Way Capital, Kelvin Capital, and the Scottish Investment Bank.
NT
Novel Technologies Holdings
Novel Technologies Holdings develops permanent silver-based antimicrobial treatments for textiles and surfaces.
£2.0MTotal raised
Novel Technologies Holdings developed an eco-friendly antimicrobial technology that encapsulates pure silver within textile fibres. The company is expanding its applications into sectors including healthcare, activewear, paints, and coatings.
Categories
Team
DE
David Evans
Founder
ZA
Zahir Ahmad
CTO
SW
Stewart White
Executive Chairman
Stewart serves as executive chairman of Novel Technologies Holdings and chairs The Electrospinning Company. He also holds non-executive directorships at Cytomos and PneumoWave, alongside an academic role as professor in practice at the University of Glasgow.
LinkedInInvestors
Funding history
£2.0M